Carey OConnor Kolaja

Insider Reports History

Entity
Individual
Location
C/O Revance Therapeutics, Inc, 1222 Demonbreun Street, Suite 1001, Nashville, Tennessee
Signature
/s/ Dwight Moxie, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Carey OConnor Kolaja:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Revance Therapeutics, Inc. Director Common Stock 31.6K $120K $3.80 May 1, 2024 Direct
Revance Therapeutics, Inc. Director Stock Option (Right to buy) 23.5K May 1, 2024 Direct

Insider Reports Filed by Carey OConnor Kolaja

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RVNC Revance Therapeutics, Inc. May 1, 2024 2 $0 4 May 3, 2024 Director
RVNC Revance Therapeutics, Inc. Jun 15, 2023 3 -$25.3K 4 Jun 20, 2023 Director
RVNC Revance Therapeutics, Inc. May 3, 2023 2 $0 4 May 5, 2023 Director
RVNC Revance Therapeutics, Inc. May 4, 2022 1 $0 4/A May 13, 2022 Director
RVNC Revance Therapeutics, Inc. May 5, 2021 2 $0 4 May 7, 2021 Director